Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Demetrius Albanes

Showing results (401-410 of 593) with videos related to

Pageof 60
Sort By:
Cancer Research|February 28, 2007
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal womenChristopher A Haiman, Laure Dossus, V Wendy Setiawan, et al.
JAMA Oncology|September 21, 2023
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate CancerBurcu F Darst, Ed Saunders, Tokhir Dadaev, et al.
Ebiomedicine|February 1, 2024
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysisJames Yarmolinsky, Jamie W Robinson, Daniela Mariosa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Veronica Wendy Setiawan, Fredrick R Schumacher, Christopher A Haiman, et al.
European Urology|October 4, 2014
A genome-wide pleiotropy scan for prostate cancer riskOrestis A Panagiotou, Ruth C Travis, Daniele Campa, et al.
Human Molecular Genetics|October 11, 2019
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathwaysGeffen Kleinstern, Huihuang Yan, Michelle A T Hildebrandt, et al.
Cancer Research|February 21, 2006
Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studiesHeather Spencer Feigelson, David G Cox, Howard M Cann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
Scientific Reports|July 6, 2021
Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adultsHana Zahed, Mattias Johansson, Per M Ueland, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Pageof 60

Showing results (401-410 of 593) with videos related to

Sort By:
Pageof 60
Cancer Research|February 28, 2007
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal womenChristopher A Haiman, Laure Dossus, V Wendy Setiawan, et al.
JAMA Oncology|September 21, 2023
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate CancerBurcu F Darst, Ed Saunders, Tokhir Dadaev, et al.
Ebiomedicine|February 1, 2024
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysisJames Yarmolinsky, Jamie W Robinson, Daniela Mariosa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Veronica Wendy Setiawan, Fredrick R Schumacher, Christopher A Haiman, et al.
European Urology|October 4, 2014
A genome-wide pleiotropy scan for prostate cancer riskOrestis A Panagiotou, Ruth C Travis, Daniele Campa, et al.
Human Molecular Genetics|October 11, 2019
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathwaysGeffen Kleinstern, Huihuang Yan, Michelle A T Hildebrandt, et al.
Cancer Research|February 21, 2006
Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studiesHeather Spencer Feigelson, David G Cox, Howard M Cann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
Scientific Reports|July 6, 2021
Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adultsHana Zahed, Mattias Johansson, Per M Ueland, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Pageof 60